Workflow
Guangdong Dtech Technology (301377)
icon
Search documents
鼎泰高科(301377) - 关于向境外全资子公司增加投资的公告
2025-04-22 12:04
证券代码:301377 证券简称:鼎泰高科 公告编号:2025-018 关于向境外全资子公司增加投资的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、本次增加投资概述 广东鼎泰高科技术股份有限公司(以下简称"公司")为深化战略布局,进 一步推动海外业务的发展,计划使用自有资金或自筹资金向境外全资子公司增加 投资不超过 3 亿元(或等值外币)。其中,向鼎泰高科(泰国)有限公司(以下 简称"泰国子公司")增加投资不超过 2 亿元(或等值外币),向德国鼎泰高科 技术有限公司(以下简称"德国子公司")增加投资不超过 1 亿元(或等值外币)。 公司于 2025 年 4 月 21 日召开第二届董事会第十一次会议审议通过了《关于 向境外全资子公司增加投资的议案》。根据《深圳证券交易所创业板股票上市规 则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》及《公司章程》等相关规定,本次增资事项在公司董事会审议权限范围内, 无需提交公司股东大会审批。 本次增资不构成关联交易,亦不构成《上市公司重大资产重组管理办法》规 定的重大资产重组。 二、 ...
鼎泰高科(301377) - 2024年度监事会工作报告
2025-04-22 12:04
广东鼎泰高科技术股份有限公司 2024 年度监事会工作报告 2024 年度,广东鼎泰高科技术股份有限公司(以下简称"公司")监事会严格按 照《中华人民共和国公司法》(以下简称"《公司法》")《中华人民共和国证券 法》(以下简称"《证券法》")等法律法规和《广东鼎泰高科技术股份有限公司 章程》(以下简称"《公司章程》")《监事会议事规则》等规章制度的规定,本 着对公司和全体股东负责的态度,勤勉尽责履行职责和义务,独立行使监事会的监 督职权和职责。对公司经营活动、财务状况、对外担保、关联交易、股权激励、董 事会召开程序及董事、高级管理人员履行职责情况等实施了有效监督,维护了公司 和全体股东合法利益,促进公司规范运作。现将公司 2024 年度监事会工作情况汇报 如下: 一、2024年度监事会工作情况 报告期内,公司监事会共召开7次会议,审议通过了27项议案,会议的通知、召 开及表决程序均合法、独立、透明,符合有关法律法规和《公司章程》的要求。会 议具体情况如下: | 序号 | 召开届次 | 召开时间 | 议案内容 | | --- | --- | --- | --- | | 1 | 第二届监事会 | 2024 年 1 ...
鼎泰高科(301377) - 关于2025年度公司董事、监事、高级管理人员薪酬方案的公告
2025-04-22 12:04
证券代码:301377 证券简称:鼎泰高科 公告编号:2025-010 广东鼎泰高科技术股份有限公司 本次董事、监事薪酬方案适用期限自公司2024年年度股东大会审议通过之日 起至新的薪酬方案审批通过之日止,高级管理人员薪酬方案适用期限自公司第二 届董事会第十一次会议审议通过之日起至新的薪酬方案审批通过之日止。 三、薪酬标准 (一)董事薪酬标准 关于2025年度公司董事、监事、高级管理人员 薪酬方案的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 广东鼎泰高科技术股份有限公司(以下简称"公司")于2025年4月21日召 开第二届董事会第十一次会议、第二届监事会第十一次会议,分别审议通过了《关 于2025年度公司董事薪酬的议案》《关于2025年度公司高级管理人员薪酬的议案》 《关于2025年度公司监事薪酬的议案》,董事和监事薪酬方案尚需提交公司股东 大会审议。 根据《公司章程》《薪酬与考核委员会议事规则》等相关制度,结合公司经 营规模等实际情况并参照行业薪酬水平,公司制定了2025年度董事、监事及高级 管理人员薪酬方案。现将具体情况公告如下: 一、适用对象 ...
鼎泰高科(301377) - 关于向银行申请综合授信额度并提供担保的公告
2025-04-22 12:04
证券代码:301377 证券简称:鼎泰高科 公告编号:2025-015 单位:万元 广东鼎泰高科技术股份有限公司 关于向银行申请综合授信额度并提供担保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 广东鼎泰高科技术股份有限公司(以下简称"公司"或"鼎泰高科")于 2025 年 4 月 21 日召开第二届董事会第十一次会议及第二届监事会第十一次会议, 审议通过《关于向银行申请综合授信额度并提供担保的议案》,具体情况如下: 一、申请银行授信额度及担保事项概述 为满足日常经营所需资金和业务发展需要、积极拓宽资金渠道,公司及全资 子公司广东鼎泰机器人科技有限公司(以下简称"鼎泰机器人")、南阳鼎泰高 科有限公司(以下简称"南阳鼎泰")、东莞市鼎泰鑫电子有限公司(以下简称 "鼎泰鑫电子")、东莞市鼎泰华南采购服务有限公司(以下简称"鼎泰华南采 购")、东莞市超智新材料有限公司(以下简称"东莞超智")拟向银行及其他 金融机构申请额度不超过人民币 16 亿元的综合授信额度。授信品类包括但不限 于公司日常生产经营的长、短期贷款、银行承兑汇票、贸易融资、保函、信用证 等 ...
鼎泰高科(301377) - 第二届董事会2025年第一次独立董事专门会议审查意见
2025-04-22 12:04
经核查,本次公司(包括子公司)向银行申请综合授信额度并接受关联方担 保事项符合有关法律法规的规定,有利于公司的长远发展,不存在损害公司或中 小股东利益的情形。公司关联方为公司向银行申请综合授信额度提供连带责任保 证担保,公司不提供反担保且免于支付担保费用事项,该事项是为了解决公司经 营发展的资金需求,不存在损害公司及全体股东利益的情形。因此,同意将该议 案提交至公司第二届董事会第十一次会议审议。 二、关于 2025 年度日常关联交易预计的审查意见 经核查,公司对关联方预计的 2025 年度日常关联交易遵守公开、公平、公 正的原则,交易价格以市场价格为定价依据,定价公允,符合相关法律法规和《公 司章程》的规定,定价公平、合理,不存在损害公司及非关联方股东利益的情况。 因此,同意将该议案提交至公司第二届董事会第十一次会议审议。 广东鼎泰高科技术股份有限公司 第二届董事会 2025 年第一次独立董事专门会议审查意见 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司治理准 则》《上市公司独立董事管理办法》及《深圳证券交易所创业板股票上市规则》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 ...
鼎泰高科(301377) - 2024 Q4 - 年度财报
2025-04-22 12:00
Financial Performance - The company's operating revenue for 2024 reached ¥1,579,629,986.34, representing a 19.65% increase compared to ¥1,320,224,629.77 in 2023[18]. - The net profit attributable to shareholders for 2024 was ¥226,870,061.03, a 3.45% increase from ¥219,307,938.56 in 2023[18]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥201,959,224.13, reflecting a 14.76% increase from ¥175,988,071.25 in 2023[18]. - The net cash flow from operating activities for 2024 was ¥273,194,717.93, a significant increase of 49.87% compared to ¥182,293,092.59 in 2023[18]. - The total assets at the end of 2024 amounted to ¥3,520,596,286.88, marking a 10.73% increase from ¥3,179,443,666.55 at the end of 2023[18]. - The net assets attributable to shareholders at the end of 2024 were ¥2,476,792,851.01, up 6.81% from ¥2,318,803,454.08 at the end of 2023[18]. - The company reported a basic earnings per share of ¥0.55 for 2024, a 3.77% increase from ¥0.53 in 2023[18]. - The company achieved total revenue of CNY 1.58 billion in 2024, representing a year-on-year growth of 19.65%[50]. - The net profit attributable to shareholders was CNY 227 million, up 3.45% year-on-year, while the net profit excluding non-recurring items was CNY 202 million, increasing by 14.76%[50]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 2.8 RMB per 10 shares to all shareholders, based on a total share capital of 410,000,000 shares[4]. - A cash dividend of RMB 2.8 per 10 shares was approved, totaling RMB 114,800,000.00, which represents 100% of the total profit distribution[154][157]. - The company has a stable and clear profit distribution policy, ensuring continuous and reasonable returns to investors[155]. - The profit distribution proposal must be approved by a majority of the board, including more than half of the independent directors, and subsequently submitted to the shareholders' meeting for approval[182]. Research and Development - The company has a strong focus on research and development in new technologies and products, aiming to enhance its market position[4]. - The total amount of R&D investment for 2024 is ¥109,597,177.32, representing 6.94% of operating revenue[59]. - Research and development expenses increased by 12.15% to ¥109,597,177.32, primarily due to increased investment in R&D materials and direct labor[56]. - The number of R&D personnel increased by 7.18% to 373, with a notable rise in the number of personnel holding a master's degree, up 61.11%[59]. - The company is currently developing several new products, including high-end chip substrates and automotive display screen light control films, aimed at enhancing market competitiveness[57]. Market Expansion and Strategy - The company is exploring market expansion opportunities to increase its footprint in the PCB industry[4]. - The management team has outlined future growth strategies that include potential mergers and acquisitions to bolster its competitive edge[4]. - The company plans to enhance its market share in high-end products and expand into Southeast Asia and other global markets by leveraging its bases in Thailand and Germany[94]. - Future strategies include potential market expansion and new product development initiatives[136]. Corporate Governance - The company emphasizes the importance of accurate financial reporting and has confirmed that all board members attended the meeting to review the annual report[4]. - The board of directors consists of 7 members, including 3 independent directors, complying with legal and regulatory requirements[106]. - The company’s internal audit department operates independently, reporting directly to the audit committee, to enhance governance standards[110]. - The company has established a comprehensive internal management structure, ensuring operational independence from the controlling shareholder[118]. - The management team is focused on strategic growth and operational efficiency, leveraging their extensive backgrounds in the electronics and technology sectors[127]. Environmental and Social Responsibility - The company has implemented measures to reduce carbon emissions, achieving a reduction of 40.88 tons of CO2 emissions annually through clean production initiatives[168]. - The company received national recognition as a green factory in 2024, promoting green production and forming an environmentally friendly economic cycle[168]. - The company has established a comprehensive employee rights protection system, emphasizing equal employment opportunities and prohibiting discrimination based on gender, age, ethnicity, religion, and region[170]. - The company conducts regular health checks for employees in hazardous positions and provides protective gear to ensure their health and safety[175]. Financial Management and Compliance - The company has confirmed that it has complied with all commitments made in the prospectus, ensuring no losses to investors due to unfulfilled commitments[187]. - The company will begin to recognize warranty costs as part of operating costs starting from the 2024 fiscal year, with no cumulative impact on retained earnings for prior periods[189]. - The company has appointed Rongcheng Accounting Firm as the internal control auditing firm, with audit fees totaling CNY 200,000 during the reporting period[193]. - The company will comply with any new requirements or regulations from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding share buybacks[184]. Employee Management - The total number of employees at the end of the reporting period was 3,429, with 2,136 in production roles and 856 in technical positions[148][150]. - The company has a comprehensive training program in place to enhance employee skills and organizational performance, utilizing various learning methods[152]. - The company has a competitive compensation structure, aligning with market standards and enhancing employee motivation[151]. - The company has implemented a stock incentive plan, granting a total of 6,468,200 restricted shares, with an initial grant price of RMB 11.32 per share[159].
鼎泰高科(301377) - 2025 Q1 - 季度财报
2025-04-22 12:00
Financial Performance - The company's revenue for Q1 2025 reached ¥423,285,501.23, representing a 27.21% increase compared to ¥332,755,510.87 in the same period last year[5] - Net profit attributable to shareholders was ¥72,584,358.60, marking a significant increase of 78.51% from ¥40,661,339.93 year-on-year[5] - Basic and diluted earnings per share increased by 80.00% to ¥0.18 from ¥0.10 in the same period last year[5] - Total operating revenue for Q1 2025 reached ¥423,285,501.23, an increase of 27.2% compared to ¥332,755,510.87 in the same period last year[19] - Net profit for the period was ¥72,124,049.99, representing a 76.5% increase from ¥40,785,288.38 in the previous year[20] - Earnings per share (EPS) for the current period was ¥0.18, compared to ¥0.10 in the same period last year[21] Cash Flow and Investments - The net cash flow from operating activities was negative at -¥8,680,558.41, a decline of 147.18% compared to a positive cash flow of ¥18,400,486.27 in the previous year[9] - Operating cash flow from sales increased to $343.66 million from $311.36 million, representing a growth of 10.35% year-over-year[23] - Cash inflow from investment activities totaled $767.51 million, significantly up from $544.13 million, marking an increase of 41.2%[24] - Cash outflow from investment activities rose to $844.40 million from $605.86 million, resulting in a net cash flow from investments of -$76.89 million[24] - Cash inflow from financing activities increased to $139.57 million from $49.17 million, a growth of 184.5%[24] - Net cash flow from financing activities improved to $82.47 million compared to $8.30 million in the previous period[24] - The ending cash and cash equivalents balance was $165.28 million, up from $155.61 million, reflecting a positive change[24] - The company reported a significant increase in tax refunds received, totaling $306,691.24 compared to $98,884.50 previously[23] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,614,715,584.63, up 2.67% from ¥3,520,596,286.88 at the end of the previous year[5] - Total liabilities rose to ¥1,059,983,171.63, compared to ¥1,041,129,305.08 in the previous year[17] - Current assets totaled ¥2,239,351,845.46, an increase from ¥2,160,708,019.10 year-on-year[17] - Non-current assets amounted to ¥1,375,363,739.17, slightly up from ¥1,359,888,267.78 in the previous year[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,281[11] - The largest shareholder, Guangdong Taiding Holdings, holds 76.23% of the shares, totaling 312,552,000 shares[11] - The company has a significant shareholder structure, with Guangdong Taiding Holdings owning 76.23% of the shares[12] - The top ten shareholders include entities like Nanyang Ruihai Electronic Product Consulting Center, holding 5,783,708 shares[12] Operational Insights - The company experienced a 33.99% increase in contract liabilities, reaching ¥8,334,668.72 compared to ¥6,220,307.30 in the previous year[8] - The company reported a cash balance of ¥293,580,572.50 at the end of the period, an increase from ¥231,725,392.08 at the beginning[15] - The company's trading financial assets decreased to ¥558,443,034.24 from ¥604,860,008.23[15] - Accounts receivable remained stable at ¥649,952,160.61, slightly up from ¥649,668,528.97[15] - The company saw an increase in receivables financing to ¥97,398,358.71 from ¥61,408,383.75, indicating improved liquidity management[15] - Inventory levels rose to ¥395,702,266.84 from ¥389,134,055.61, reflecting potential growth in sales[15] Future Outlook - The company is exploring new strategies for market expansion and product development, although specific details were not disclosed in the call[12] - Future guidance remains optimistic, with expectations for continued growth in key financial metrics[12]
鼎泰高科(301377) - 关于2024年度利润分配预案的公告
2025-04-22 11:59
证券代码:301377 证券简称:鼎泰高科 公告编号:2025-013 广东鼎泰高科技术股份有限公司 关于 2024 年度利润分配预案的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏。 一、审议程序 广东鼎泰高科技术股份有限公司(以下简称"公司")于 2025 年 4 月 21 日 召开第二届董事会第十一次会议、第二届监事会第十一次会议,审议通过《关于 2024 年度利润分配预案的议案》,本议案尚需提交公司股东大会审议。 二、利润分配预案的基本情况 经容诚会计师事务所(特殊普通合伙)审计,公司 2024 年度母公司实现净 利润 134,072,284.60 元,提取法定盈余公积金 13,407,228.46 元,加上年初未分配 利润 183,797,594.26 元,扣除已支付 2024 年半年度现金分红 82,000,000.00 元, 实际可供分配利润为 222,462,650.40 元。公司 2024 年度合并报表可供分配利润 为 944,136,446.36 元。根据《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作》规定,按 ...